Portfolio Tracker
Dein Depot in Echtzeit – Kurse, Renditeanalyse und Dividendenplaner an einem Ort.
Anzeige

Bangkok Hospital Invests in State-of-the-Art Robot-Assisted Surgery to Elevate Patient Care through Surgical Innovation 01.07.2024, 10:15 Uhr von EQS News Jetzt kommentieren: 0


EQS Newswire / 01/07/2024 / 10:15 CET/CEST

BANGKOK, THAILAND - Media OutReach Newswire - 1 July 2024 - Bangkok Hospital, a leading healthcare provider in Thailand, has invested over 200 million baht to establish a cutting-edge robotic surgery center. The facility is equipped with multiple operating rooms integrated with the latest robotic platforms, including the da Vinci Xi Surgical System. This investment underscores the hospital's commitment to becoming the premier destination for robotic-assisted surgery in Southeast Asia.

508804-image-1-jpeg-550x.jpeg

Having successfully completed 200 cases, Bangkok Hospital showcases its expertise in leveraging state-of-the-art technology to deliver superior patient outcomes. The hospital's strategic vision is to become the robotic hub of Southeast Asia, making advanced surgical treatments more accessible to patients throughout the region at competitive prices.

The da Vinci Xi Surgical System enables surgeons to perform complex procedures with improved precision and better dexterity. Conditions that can benefit from robot-assisted surgery include thoracic diseases like lung cancer; urological diseases such as prostate and kidney cancers; abdominal and hepato-pancreato-biliary diseases including hernias and liver cancer; as well as gynecological diseases like uterine fibroid and ovarian mass.

"We are dedicated to addressing the unique healthcare challenges faced by Southeast Asia, including the growing burden of cancers, an aging population, and disparities in access to quality care," said Dr. Ekkit Surakarn, Deputy Hospital Director of Bangkok Hospital. "Our robot-assisted surgery program is centered around delivering tangible benefits and value to our patients, while actively engaging with insurance providers to expand coverage for these advanced treatments."

The hospital has achieved remarkable outcomes, with significant improvements in key operating indicators such as reduced blood loss, shorter recovery time, faster patient mobilization, decreased risk of infection, and unplanned readmission. In specific procedures, the use of robotic systems has enabled nerve-sparing techniques while preserving urinary function in prostate cancer cases and improved lymph node removal in lung cancer cases.

Bangkok Hospital's multidisciplinary approach brings together highly skilled medical teams to create personalized treatment plans and deliver comprehensive care throughout the patient's journey. The hospital's 5-year roadmap includes expanding its robotic surgery capabilities, covering more specialties such as ear-nose-throat surgery while investing in education and training to establish Bangkok Hospital as a regional center for skill development.

"We remain dedicated to advancing the frontiers of robotic surgery and expanding its benefits to patients across Asia," stated Dr. Ekkit Surakarn.

For more information about Bangkok Hospital's Robotic Surgery Institute, please visit: https://www.bangkokhospital.com/en/campaign/robotic-surgery

Hashtag: #BangkokHospital

The issuer is solely responsible for the content of this announcement.

About Bangkok Hospital:

Bangkok Hospital is a leading healthcare provider in Thailand, offering a comprehensive range of medical services to local and international patients. With a team of highly skilled healthcare professionals and state-of-the-art facilities, the hospital is committed to delivering exceptional patient care and driving medical innovation in the region.

225647
News Source: Bangkok Hospital

01/07/2024 Dissemination of a Financial Press Release, transmitted by EQS News.
The issuer is solely responsible for the content of this announcement.

Media archive at www.todayir.com

fncls.ssp?fn=show_t_gif&application_id=1936893&application_name=news&site_id=boersennews_de~~~d41e2cc8-bdcb-47ba-bb51-c77a04513666
Kommentare (0) ... diskutiere mit.
k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
Schreib den ersten Kommentar!

Dis­clai­mer: Die hier an­ge­bo­te­nen Bei­trä­ge die­nen aus­schließ­lich der In­for­ma­t­ion und stel­len kei­ne Kauf- bzw. Ver­kaufs­em­pfeh­lung­en dar. Sie sind we­der ex­pli­zit noch im­pli­zit als Zu­sich­er­ung ei­ner be­stim­mt­en Kurs­ent­wick­lung der ge­nan­nt­en Fi­nanz­in­stru­men­te oder als Handl­ungs­auf­for­der­ung zu ver­steh­en. Der Er­werb von Wert­pa­pier­en birgt Ri­si­ken, die zum To­tal­ver­lust des ein­ge­setz­ten Ka­pi­tals füh­ren kön­nen. Die In­for­ma­tion­en er­setz­en kei­ne, auf die in­di­vi­du­el­len Be­dür­fnis­se aus­ge­rich­te­te, fach­kun­di­ge An­la­ge­be­ra­tung. Ei­ne Haf­tung oder Ga­ran­tie für die Ak­tu­ali­tät, Rich­tig­keit, An­ge­mes­sen­heit und Vol­lständ­ig­keit der zur Ver­fü­gung ge­stel­lt­en In­for­ma­tion­en so­wie für Ver­mö­gens­schä­den wird we­der aus­drück­lich noch stil­lschwei­gend über­nom­men. Die Mar­kets In­side Me­dia GmbH hat auf die ver­öf­fent­lich­ten In­hal­te kei­ner­lei Ein­fluss und vor Ver­öf­fent­lich­ung der Bei­trä­ge kei­ne Ken­nt­nis über In­halt und Ge­gen­stand die­ser. Die Ver­öf­fent­lich­ung der na­ment­lich ge­kenn­zeich­net­en Bei­trä­ge er­folgt ei­gen­ver­ant­wort­lich durch Au­tor­en wie z.B. Gast­kom­men­ta­tor­en, Nach­richt­en­ag­en­tur­en, Un­ter­neh­men. In­fol­ge­des­sen kön­nen die In­hal­te der Bei­trä­ge auch nicht von An­la­ge­in­te­res­sen der Mar­kets In­side Me­dia GmbH und/oder sei­nen Mit­ar­bei­tern oder Or­ga­nen be­stim­mt sein. Die Gast­kom­men­ta­tor­en, Nach­rich­ten­ag­en­tur­en, Un­ter­neh­men ge­hör­en nicht der Re­dak­tion der Mar­kets In­side Me­dia GmbH an. Ihre Mei­nung­en spie­geln nicht not­wen­di­ger­wei­se die Mei­nung­en und Auf­fas­sung­en der Mar­kets In­side Me­dia GmbH und de­ren Mit­ar­bei­ter wie­der. Aus­führ­lich­er Dis­clai­mer